Image-guided radiotherapy developer ViewRay said it will sell $13.8 million in common stock in a financing effort led by current investors as it prepares to launch its MRIdian linear accelerator technology.
The financing is being led by several of the company's existing investors, including OrbiMed Advisors, Xeraya Capital, and Kearny Venture Partners, along with two board members, ViewRay said.
The action strengthens the company's balance sheet as it prepares to introduce its MRIdian technology, said President and CEO Chris Raanes.